T80.419D Rh incompatibility with hemolytic transfusion reaction, unspecified, subsequent encounter

Name of the Condition

• Rh incompatibility with hemolytic transfusion reaction, unspecified, subsequent encounter.

Summary

This condition describes an immune-mediated hemolytic reaction occurring when Rh-negative individuals receive Rh-positive blood or blood products, leading to the destruction of red blood cells (hemolysis). It results from the recipient’s immune system recognizing Rh antigens as foreign, triggering antibody production and subsequent hemolysis. The "subsequent encounter" designation indicates this is a follow-up visit for the condition.

Causes

The reaction is triggered by the presence of Rh-positive red blood cells in an Rh-negative recipient, which the immune system identifies as foreign. This initiates antibody production, causing hemolysis. Transfusions of whole blood, packed red blood cells, or plasma products containing Rh-positive cells are common sources.

Risk Factors

• Rh-negative blood type
• Prior exposure to Rh-positive blood (e.g., previous transfusions or pregnancy)
• Inadequate crossmatching or typing before transfusion
• Use of blood products with unknown Rh status

Symptoms

• Fever, chills, or rigors
• Jaundice or dark urine (hemoglobinuria)
• Anemia-related fatigue or pallor
• Shortness of breath or tachycardia
• Abdominal or back pain
• Elevated bilirubin levels (laboratory finding)

Diagnosis

Diagnosis involves confirming Rh incompatibility through blood typing and crossmatching, along with clinical assessment of transfusion history. Laboratory tests may include direct antiglobulin testing (Coombs test) and bilirubin levels to evaluate hemolysis.

Treatment Options

Treatment focuses on managing hemolysis and preventing further reactions. This may include discontinuing the transfusion, administering intravenous fluids, and using medications to support kidney function or reduce immune response. In severe cases, additional transfusions with Rh-negative blood may be necessary.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and timely intervention. Most patients recover with appropriate treatment, but delayed or severe reactions can lead to complications. Follow-up care typically involves monitoring for recurrence and assessing long-term effects.

Complications

• Acute kidney injury due to hemoglobin release
• Disseminated intravascular coagulation (DIC)
• Severe anemia requiring additional transfusions
• Shock or multi-organ failure in extreme cases

Lifestyle & Prevention

Prevention relies on accurate blood typing and crossmatching before transfusions. Rh-negative individuals should avoid exposure to Rh-positive blood products unless necessary. Healthcare providers should verify blood compatibility and document transfusion reactions promptly.

When to Seek Professional Help

Seek immediate medical attention if symptoms such as fever, chills, jaundice, or severe pain occur during or after a blood transfusion. Early intervention can reduce the risk of complications.

Tips for Medical Coders

Document the encounter as a subsequent visit for Rh incompatibility with hemolytic transfusion reaction. Ensure the medical record specifies the condition is being managed after the initial acute phase. Include details about follow-up care, monitoring, or ongoing treatment to support the "subsequent encounter" code assignment.